HCA Healthcare, Inc.
421.83USD
+19.8100 (+4.93%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 60.2B | 65.0B | 70.6B | 75.6B | 78.5B | 81.6B |
| Q1 | 14.9B | 15.6B | 17.3B | 18.3B | 19.1B | — |
| Q2 | 14.8B | 15.9B | 17.5B | 18.6B | — | — |
| Q3 | 15.0B | 16.2B | 17.5B | 19.2B | 19.4B | — |
| Q4 | 15.5B* | 17.3B* | 18.3B* | 19.5B* | 19.9B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 19.15 | 18.97 | 22.00 | 28.33 | 29.49 | 32.07 |
| Q1 | 4.14 | 4.85 | 5.93 | 6.45 | 7.15 | — |
| Q2 | 3.90 | 4.29 | 5.53 | 6.83 | — | — |
| Q3 | 3.91 | 3.91 | 4.88 | 6.96 | 6.70 | — |
| Q4 | 7.06* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 5.81* |
| 5.49* |
| 7.84* |
| 8.01 |
| — |